Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02181426 · ClinicalTrials.gov registry record · NA
Dose Response of Ketorolac in Knee Arthroscopy
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
NCT02181426 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 112 participants.
The verdict
NCT02181426, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
Study Summary
Ketorolac is administered as current practice to the majority of patients undergoing knee arthroscopy, the appropriate dose of ketorolac to be administered has not been evaluated.
Interventions
- DRUG Ketorolac Dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2012-03 |
| Est. Completion | 2016-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02181426
The ClinicalTrials.gov registry entry for NCT02181426 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ketorolac Dose is the first listed.
NCT02181426 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02181426 about?
NCT02181426 is a clinical study titled "Dose Response of Ketorolac in Knee Arthroscopy". Ketorolac is administered as current practice to the majority of patients undergoing knee arthroscopy, the appropriate dose of ketorolac to be administered has not been evaluated.
What is the current status of trial NCT02181426?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2012-03. Estimated completion is 2016-12-15.
What interventions are being tested in trial NCT02181426?
The interventions under investigation include: Ketorolac Dose (DRUG).
Who is sponsoring clinical trial NCT02181426?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.